ServiceTitan [TTAN]
As of 2026-07-29 · Catalyst Criteria: MEASURED (informs monitoring; blocks nothing)
No date in this document is fabricated. Every entry is either (a) a date the company has filed or announced, marked CONFIRMED, or (b) a date derived from the company's own six-observation reporting-lag record, marked ESTIMATED with the derivation shown. Where I do not know a date, the row says so.
TTAN's fiscal year ends January 31. Earnings are released via 8-K Ex-99.1.
| Quarter | Quarter end | Release date | Lag (days) | Weekday |
|---|---|---|---|---|
| Q3 FY25 | 2024-10-31 | 2025-01-13 | 74 | Mon (IPO quarter — excluded from the estimate) |
| Q4 FY25 | 2025-01-31 | 2025-03-13 | 41 | Thu |
| Q1 FY26 | 2025-04-30 | 2025-06-05 | 36 | Thu |
| Q2 FY26 | 2025-07-31 | 2025-09-04 | 35 | Thu |
| Q3 FY26 | 2025-10-31 | 2025-12-04 | 34 | Thu |
| Q4 FY26 | 2026-01-31 | 2026-03-12 | 40 | Thu |
| Q1 FY27 | 2026-04-30 | 2026-06-04 | 35 | Thu |
Pattern: 34–41 days after quarter end, always a Thursday (Q1/Q2/Q3 cluster at 34–36 days; Q4, which carries the audit, at 40–41). Six observations. The estimates below apply that rule and nothing else.
| Date | Confidence | Event | What it resolves | Thesis link |
|---|---|---|---|---|
| ~2026-09-03 (Thu) | ESTIMATED — Q2 end 2026-07-31 + 34 days, Thursday convention. Range 2026-08-27 → 2026-09-10. Not announced. | Q2 FY27 earnings | The single most important event in this calendar. Four things print together: (1) Max location disclosure — whether management gives an absolute count/ARR or repeats "doubled again" off an unstated base; (2) GTV growth — the mechanism; (3) whether the 6-for-6 guidance-beat pattern holds against the $284–286m guide; (4) the FY27 guide walk-up from $1,130–1,140m. | Research §2 (mechanism), Valuation §3 (estimate build), Trade I1 & I4 |
| ~2026-09-10 | ESTIMATED — prior-year Q2 10-Q filed 6 days after the release | Q2 FY27 Form 10-Q | NRR disclosure (does it break the ">110%" floor?); cash R&D; contract-asset/DSO build; usage-vs-GTV take rate | Trade I2, I5, I6 |
| Q2 FY27 guide already issued | CONFIRMED (8-K 2026-06-04) | Q2 FY27 revenue $284–286m; non-GAAP operating income $38–39m | Implies +17.7% YoY. The demonstrated +4.57% mean beat implies ~$298m (+23.1%). The gap between those two is the near-term variant. | Valuation §3.2 |
| FY27 guide already issued | CONFIRMED (8-K 2026-06-04) | FY27 revenue $1,130–1,140m; non-GAAP operating income $142–147m | Guide implies +18.1%; house estimate $1,190m (+23.8%) | Valuation §3.2 |
| ~2026-12-03 (Thu) | ESTIMATED — Q3 end 2026-10-31 + 33 days, Thursday convention | Q3 FY27 earnings | Second FY27 guide walk-up. Whether the walk-up pattern (FY26: $900m → $915m → $937.5m → $952m → $961m actual) repeats. Seasonally the weakest GTV quarter. | Valuation §3.1, Trade tranche 3 |
| ~2027-03-11 (Thu) | ESTIMATED — FY end 2027-01-31 + 39 days, Thursday convention | Q4 / FY27 results and FY28 initial guide | The de-rate risk event. FY26's initial guide was 6.8% below the eventual actual. If the FY28 initial guide is set at, say, +15–16%, the stock trades on the guide, not on the pattern, for a quarter. Also: FY27 GDR (annual disclosure), FY27 Active Customer count (annual), full-year non-GAAP margin. | Trade I3, I4 |
| ~2027-03-25 | ESTIMATED — FY26 10-K filed 13 days after the FY26 release | FY27 Form 10-K | Annual-only disclosures: GDR, Active Customers, FY revenue mix, Co-Founder RSU status | Research §4.5 |
| ~June 2027 | ESTIMATED — 2025 AGM 2025-06-18, 2026 AGM 2026-06-17 | 2027 Annual Meeting | Governance only. Class B holds ~73% of voting power; outcomes are not in question. | Research §8 |
These have no date and are listed so they are not mistaken for scheduled events.
| Item | Status | Why it matters |
|---|---|---|
| $140 Co-Founder RSU VWAP hurdle | Undated; contingent on price. Expires 2034-10-21 (CONFIRMED, 10-Q). | On a six-month or 90-day VWAP at $140, 6,483,088 shares (+6.8%) vest. Spot $78.40 — the hurdle is 78.6% away. Mechanical dilution on success. |
| S&P 500 / S&P MidCap index inclusion | Not eligible. S&P US index methodology requires positive GAAP earnings in the most recent quarter and in the trailing four quarters summed. TTAN's Q1 FY27 GAAP net loss was $(22.8)m and TTM is a loss. | Frequently assumed as a catalyst for recent large IPOs. It is not available here and will not be until GAAP profitability, which is not in the guided horizon. Stated to prevent it being counted. |
| Russell reconstitution | Annual, late June. TTAN was public and eligible for the 2025 and 2026 reconstitutions. | Already absorbed. Not a forward catalyst. |
| IPO lock-up | Expired. IPO 2024-12-12; standard 180-day lock-up ran to ~June 2025. | Already absorbed. Part of the 14.67x → 5.03x de-rate in the own-multiple history. |
| Max / Atlas product announcements | Undated. Neither has an announced GA date, pricing, or customer-count disclosure in any filing. | The only company-controlled growth lever. See Trade §5.1. |
| M&A | Undated. FY26 acquisition spend was $19.8m (Conduit Tech). $421.5m cash, $250m undrawn revolver. | Capacity exists; no announced pipeline. Acquisitions have been immaterial and NRR excludes acquired customers for ~15 months, so a deal would not flatter the headline metric. |
Research §2 establishes that ~80–90% of TTAN's revenue growth is customer GTV growth, i.e. US residential trades invoicing. The thesis therefore has a macro dependency that no company-specific catalyst covers.
These are recurring public releases, not dated TTAN events, and are listed as a monitoring discipline:
I am not assigning dates to these. They are monthly/quarterly government and industry series; inventing a specific release date for one would be exactly the fabrication the brief prohibits. The monitoring rule is: read TTAN's own quarterly GTV print as the ground truth, because it is the company's actual measurement of this exposure and it is disclosed every quarter.